Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phospholipid-transporting ATPase IC (ATP8B1) is a critical membrane enzyme of the P4-ATPase family, known as a "lipid flippase." It catalyzes the ATP-dependent translocation of aminophospholipids, especially phosphatidylserine and phosphatidylcholine, from the exoplasmic to the cytosolic leaflet of biological membranes, preserving membrane asymmetry essential for cellular integrity, vesicle formation, protein targeting, and bile secretion. It functions as an obligate heterodimer with CDC50A, a non-catalytic subunit required for ER exit and flippase activity. ATP8B1 is most studied in the liver, where it maintains canalicular membrane integrity during bile acid transport; mutations cause progressive familial intrahepatic cholestasis type 1 (PFIC1) and BRIC1, severe genetic diseases resulting in impaired bile flow and liver dysfunction. ATP8B1 is also critical for vesicular trafficking in other tissues and may have broader roles in cellular homeostasis and disease susceptibility, including possible links to neurodegeneration.
Drugs influencing ATP8B1 function would likely alter its aminophospholipid flippase activity, affecting the distribution of phosphatidylserine and possibly other phospholipids; perifosine uptake is one described mechanism. Potential restoration or modulation of membrane lipid asymmetry, especially in the context of hepatobiliary diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phospholipid-transporting ATPase IC (ATP8B1).